Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Jayne

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 30, 2016
Opponent's commentsMaria Fernandez Nieto, David R Jayne
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 4, 2016
Con: The use of calcineurin inhibitors in the treatment of lupus nephritisMaria Fernandez Nieto, David R Jayne
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 26, 2015
A historical essay on detection of anti-neutrophil cytoplasmic antibodiesNiels Rasmussen, Allan Wiik, David R Jayne
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 24, 2004
Renal vasculitis--an update in 2004Anthony D Booth, Charles D Pusey, David R Jayne
The New England Journal of Medicine|August 16, 2008
Anti-glomerular basement membrane disease after alemtuzumabMenna R Clatworthy, Elizabeth F Wallin, David R Jayne
JMIR Research Protocols|February 24, 2020
Evaluation of the Safety and Efficacy of Avacopan, a C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Treated Concomitantly With Rituximab or Cyclophosphamide/Azathioprine: Protocol for a Randomized, Double-Blind, Active-Controlled, Phase 3 TrialPeter A Merkel, David R Jayne, Chao Wang, et al.
Heart (British Cardiac Society)|July 15, 2016
An unusual finding in a 57-year-old woman with new onset hypertension and a diastolic murmurJason M Tarkin, James H F Rudd, David R Jayne, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 22, 2019
Evaluation of PR3-ANCA Status After Rituximab for ANCA-Associated VasculitisMark E McClure, James Wason, Seerapani Gopaluni, et al.
The Journal of Rheumatology|November 3, 2016
Comparison of the Phenotype and Outcome of Granulomatosis with Polyangiitis Between UK and Japanese CohortsShunsuke Furuta, Afzal N Chaudhry, Yoshihiro Arimura, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 30, 2015
Lupus nephritis management guidelines comparedSuzanne Wilhelmus, Ingeborg M Bajema, George K Bertsias, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 30, 2016
Opponent's commentsMaria Fernandez Nieto, David R Jayne
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 4, 2016
Con: The use of calcineurin inhibitors in the treatment of lupus nephritisMaria Fernandez Nieto, David R Jayne
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 26, 2015
A historical essay on detection of anti-neutrophil cytoplasmic antibodiesNiels Rasmussen, Allan Wiik, David R Jayne
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 24, 2004
Renal vasculitis--an update in 2004Anthony D Booth, Charles D Pusey, David R Jayne
The New England Journal of Medicine|August 16, 2008
Anti-glomerular basement membrane disease after alemtuzumabMenna R Clatworthy, Elizabeth F Wallin, David R Jayne
JMIR Research Protocols|February 24, 2020
Evaluation of the Safety and Efficacy of Avacopan, a C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Treated Concomitantly With Rituximab or Cyclophosphamide/Azathioprine: Protocol for a Randomized, Double-Blind, Active-Controlled, Phase 3 TrialPeter A Merkel, David R Jayne, Chao Wang, et al.
Heart (British Cardiac Society)|July 15, 2016
An unusual finding in a 57-year-old woman with new onset hypertension and a diastolic murmurJason M Tarkin, James H F Rudd, David R Jayne, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 22, 2019
Evaluation of PR3-ANCA Status After Rituximab for ANCA-Associated VasculitisMark E McClure, James Wason, Seerapani Gopaluni, et al.
The Journal of Rheumatology|November 3, 2016
Comparison of the Phenotype and Outcome of Granulomatosis with Polyangiitis Between UK and Japanese CohortsShunsuke Furuta, Afzal N Chaudhry, Yoshihiro Arimura, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 30, 2015
Lupus nephritis management guidelines comparedSuzanne Wilhelmus, Ingeborg M Bajema, George K Bertsias, et al.
Pageof 3